Liaoning He Eye Hospital Group Co., LTD.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Liaoning Heshi Ophthalmology Hospital Group Co., Ltd. (hereinafter referred to as "Heshi Ophthalmology") was founded by He Wei and his team, who is a PhD in ophthalmology after studying abroad, deputy leader of the National Blindness Prevention Technical Guidance Group, executive director of the International Blindness Prevention Association Council, and executive director of the International Ophthalmology Foundation. It is a medical, educational, and research institution that adopts a three-level eye health medical service model, A group type chain eye health service institution dedicated to the management of eye health throughout its entire lifecycle. On March 22, 2022, He's Ophthalmology made its initial public offering of stocks on the Shenzhen Stock Exchange and was listed on the ChiNext (301103. SZ). The mission of He's Ophthalmology is to "build a 'bright city', and everyone wants to have He's eye health care". Adhering to the core values of "dedicating to society, trusting the people, leading innovation, and creating happiness together", we adhere to the principle of prevention first, combining prevention and treatment, and relying on advanced medical technology, talent, and diagnostic and treatment equipment, we provide comprehensive ophthalmic diagnosis and treatment services for various types of eye disease patients. We have rich clinical experience and outstanding technical advantages in diagnosis and treatment services such as cataracts, glaucoma, vitreoretinopathy, dry eyes, traditional Chinese medicine, and refractive errors; At the same time, we continue to deepen innovation in the field of gene and stem cell diagnosis and treatment, exploring new models of precision medical ophthalmology led by gene and stem cell technology, and making breakthroughs in experiments related to hereditary retinoschisis. He Wei and his team have introduced cataract phacoemulsification technology, vitrectomy technology, and fundus laser technology since the early stages of their entrepreneurship in 1995. At the same time, they have adopted innovative technological means to establish and improve He's unique tertiary eye health medical service model. At present, this model is based on internet technology, integrating online and offline resources, continuously extending offline services to pre diagnosis, during diagnosis, and post diagnosis, and constructing a medical service system centered on personal eye health, effectively supporting the sustained and rapid development of business. Considering the comprehensive capabilities of medical technology team, medical service capacity and level, medical quality status, scientific research and teaching, Shenyang Heshi Ophthalmology Hospital, the central hospital of the group, is a "national key clinical specialty", a "blindness prevention and treatment training base" of the National Health Commission, an ophthalmologist training base of the International Ophthalmology Council, and a national drug clinical trial institution; Shenyang Heshi Ophthalmology Co., Ltd. is an ISO9001 international quality management system certification unit. Proactively assuming social responsibility is a manifestation of He's core values in ophthalmology. He's ophthalmology, with a high sense of responsibility and mission, has become an important force in promoting the development of eye health by practicing social responsibility through advocacy, education and training, public welfare assistance, and other means. Awarded the "People's Corporate Social Responsibility Award" and "People's Craftsmanship Award" by People's Daily Online, the "2020 People's Livelihood Demonstration Project" nationwide, and listed on the "Enterprise Best Practice" list of the United Nations Global Compact China Network, becoming an official member of the World Association of Ophthalmic Hospitals (WAEH). In the future, He's Ophthalmology will adhere to technological innovation, accelerate talent cultivation, promote regional layout, strengthen international cooperation, fulfill social responsibilities, and continuously provide high-quality full lifecycle eye health management services for the people. |
| Headquarter | Shenyang |
| Establish Date | 10/15/2009 |
| Listed Code | 301103.SZ |
| Listed Date | 3/22/2022 |
| Chairman | He Wei. |
| CEO | He Wei. |
| Website | www.hsyk.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
